Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Convergent functional genomics: a Bayesian candidate gene identification approach for complex disorders.

B Bertsch1, C A Ogden, K Sidhu

  • 1Laboratory of Neurophenomics, Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Methods (San Diego, Calif.)
|November 26, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation precision medicine for pain.

Molecular psychiatry·2025
Same author

Next-generation precision medicine for suicidality prevention.

Translational psychiatry·2024
Same author

Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics.

Molecular psychiatry·2024
Same author

Temporal effects on death by suicide: empirical evidence and possible molecular correlates.

Discover mental health·2023
Same author

Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.

Molecular psychiatry·2023
Same author

Polyphenic risk score shows robust predictive ability for long-term future suicidality.

Discover mental health·2022

Convergent Functional Genomics (CFG) identifies high-probability candidate genes for complex disorders by integrating animal and human data. This approach prioritizes genes for further validation, offering insights into disease pathophysiology.

Area of Science:

  • Genetics
  • Neuroscience
  • Bioinformatics

Background:

  • Identifying genes for complex neuropsychiatric disorders is challenging with traditional human genetics.
  • Existing methods struggle to narrow down candidate genes from large datasets.

Purpose of the Study:

  • To introduce and validate a novel translational approach, Convergent Functional Genomics (CFG).
  • To overcome limitations in identifying disease-associated genes for complex disorders.

Main Methods:

  • CFG cross-matches animal gene expression data with human genetic linkage and postmortem brain data.
  • A Bayesian framework is used for cross-validation and uncertainty reduction.
  • Identified candidate genes are prioritized for validation through association studies and experimental models.

Related Experiment Videos

Main Results:

  • CFG significantly reduces hundreds of potential genes to a short list of high-probability candidates.
  • Bioinformatics analysis of CFG-identified gene groups reveals potential disease pathways and mechanisms.

Conclusions:

  • CFG is an effective approach for identifying and prioritizing candidate genes in complex disorders.
  • The methodology is potentially generalizable to other complex diseases beyond neuropsychiatric disorders.